Jennifer L J Heaney1, Anna C Phillips2, Douglas Carroll2, Mark T Drayson1. 1. a Clinical Immunology Service, School of Immunity and Infection, University of Birmingham , Birmingham , UK. 2. b School of Sport Exercise and Rehabilitation Sciences, University of Birmingham , Birmingham , UK.
Abstract
CONTEXT: Salivary antibodies may act as non-invasive marker of systemic immunity enabling assessment of vaccination and protection against bacterial infections. OBJECTIVE: To assess if levels of anti-pneumococcal (Pn) antibodies in saliva reflect concentrations in serum and determine whether saliva can accurately identify protective concentrations in serum. METHODS: IgG, IgA and IgM antibody levels in paired saliva and serum samples were measured against 12 Pn polysaccharide antigens in 72 healthy adults. RESULTS: Antibody levels in saliva correlated positively with serum across immunoglobulin classes, most strongly for IgA. Individuals who had protective antibody levels in serum demonstrated significantly higher IgG and IgA salivary antibody concentrations/secretion rates. Salivary IgG and IgA Pn antibodies were able to distinguish between those with/without protective levels in serum for the majority of serotypes. Salivary IgM antibodies were not able to differentiate protective status. Median IgG and IgA Pn salivary parameters were able to identify individuals who had protective levels in serum on ≥8/12 serotypes with moderate accuracy: median IgA secretion rates provided the best sensitivity (73%) and specificity (71%). CONCLUSIONS: These findings suggest that IgG and IgA Pn specific antibodies in saliva may be useful surrogate markers of antibody status in serum.
CONTEXT: Salivary antibodies may act as non-invasive marker of systemic immunity enabling assessment of vaccination and protection against bacterial infections. OBJECTIVE: To assess if levels of anti-pneumococcal (Pn) antibodies in saliva reflect concentrations in serum and determine whether saliva can accurately identify protective concentrations in serum. METHODS: IgG, IgA and IgM antibody levels in paired saliva and serum samples were measured against 12 Pn polysaccharide antigens in 72 healthy adults. RESULTS: Antibody levels in saliva correlated positively with serum across immunoglobulin classes, most strongly for IgA. Individuals who had protective antibody levels in serum demonstrated significantly higher IgG and IgA salivary antibody concentrations/secretion rates. Salivary IgG and IgA Pn antibodies were able to distinguish between those with/without protective levels in serum for the majority of serotypes. Salivary IgM antibodies were not able to differentiate protective status. Median IgG and IgA Pn salivary parameters were able to identify individuals who had protective levels in serum on ≥8/12 serotypes with moderate accuracy: median IgA secretion rates provided the best sensitivity (73%) and specificity (71%). CONCLUSIONS: These findings suggest that IgG and IgA Pn specific antibodies in saliva may be useful surrogate markers of antibody status in serum.
Authors: Veronica P Costantini; Kenny Nguyen; Zoe Lyski; Shannon Novosad; Ana C Bardossy; Amanda K Lyons; Paige Gable; Preeta K Kutty; Joseph D Lutgring; Amanda Brunton; Natalie Thornburg; Allison C Brown; L Clifford McDonald; William Messer; Jan Vinjé Journal: medRxiv Date: 2021-09-07
Authors: Veronica P Costantini; Kenny Nguyen; Zoe Lyski; Shannon Novosad; Ana C Bardossy; Amanda K Lyons; Paige Gable; Preeta K Kutty; Joseph D Lutgring; Amanda Brunton; Natalie J Thornburg; Allison C Brown; L Clifford McDonald; William Messer; Jan Vinjé Journal: J Immunol Date: 2022-02-28 Impact factor: 5.422
Authors: Stefani N Thomas; Amy B Karger; Ghaith Altawallbeh; Kathryn M Nelson; David R Jacobs; Jed Gorlin; Helene Barcelo; Bharat Thyagarajan Journal: Sci Rep Date: 2022-05-25 Impact factor: 4.996
Authors: Sian E Faustini; Sian E Jossi; Marisol Perez-Toledo; Adrian M Shields; Joel D Allen; Yasunori Watanabe; Maddy L Newby; Alex Cook; Carrie R Willcox; Mahboob Salim; Margaret Goodall; Jennifer L Heaney; Edith Marcial-Juarez; Gabriella L Morley; Barbara Torlinska; David C Wraith; Tonny V Veenith; Stephen Harding; Stephen Jolles; Mark J Ponsford; Tim Plant; Aarnoud Huissoon; Matthew K O'Shea; Benjamin E Willcox; Mark T Drayson; Max Crispin; Adam F Cunningham; Alex G Richter Journal: Immunology Date: 2021-05-24 Impact factor: 7.215
Authors: Sian E Faustini; Sian E Jossi; Marisol Perez-Toledo; Adrian Shields; Joel D Allen; Yasunori Watanabe; Maddy L Newby; Alex Cook; Carrie R Willcox; Mahboob Salim; Margaret Goodall; Jennifer L Heaney; Edith Marcial-Juarez; Gabriella L Morley; Barbara Torlinska; David C Wraith; Tonny Veenith; Stephen Harding; Stephen Jolles; Ponsford J Mark; Tim Plant; Aarnoud Huissoon; Matthew K O'Shea; Benjamin E Willcox; Mark T Drayson; Max Crispin; Adam F Cunningham; Alex G Richter Journal: medRxiv Date: 2020-06-18
Authors: Melanie A MacMullan; Albina Ibrayeva; Kylie Trettner; Laura Deming; Sudipta Das; Frances Tran; Jose Ricardo Moreno; Joseph G Casian; Prithivi Chellamuthu; Jeffrey Kraft; Kenneth Kozak; Fred E Turner; Vladimir I Slepnev; Lydia M Le Page Journal: Sci Rep Date: 2020-11-30 Impact factor: 4.379
Authors: Swinburne A J Augustine; Tarsha N Eason; Tim Wade; Shannon M Griffin; Elizabeth Sams; Kaneatra Simmons; Malini Ramudit; Kevin Oshima; Alfred Dufour Journal: Int J Environ Res Public Health Date: 2021-05-28 Impact factor: 3.390
Authors: Jenna L Riis; Hedyeh Ahmadi; Olivia Silke; Steve W Granger; Crystal I Bryce; Douglas A Granger Journal: Front Immunol Date: 2020-08-28 Impact factor: 7.561